Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.6%

119 terminated/withdrawn out of 947 trials

Success Rate

83.7%

-2.9% vs industry average

Late-Stage Pipeline

8%

80 trials in Phase 3/4

Results Transparency

44%

270 of 609 completed trials have results

Key Signals

113 recruiting270 with results79 terminated40 withdrawn

Enrollment Performance

Analytics

N/A
444(60.7%)
Phase 2
115(15.7%)
Phase 1
79(10.8%)
Phase 4
44(6.0%)
Phase 3
36(4.9%)
Early Phase 1
14(1.9%)
732Total
N/A(444)
Phase 2(115)
Phase 1(79)
Phase 4(44)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (947)

Showing 20 of 947 trials
NCT06238323Not ApplicableActive Not Recruiting

Lafiya HIV Self-testing Study Protocol

Role: lead

NCT06505122Not ApplicableTerminated

Dyadic Life Review Intervention for Older Patients With Advanced Cancer) and Their Caregivers

Role: lead

NCT06312514Not ApplicableWithdrawn

Lafiya HIV-status Neutral Study - Protocol

Role: lead

NCT03981575Recruiting

Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)

Role: collaborator

NCT07374939Not Yet Recruiting

Medical Cannabis Observational Study for Antiemetic Intervention in Chemotherapy

Role: lead

NCT04098666Phase 2Active Not Recruiting

Metformin in Alzheimer's Dementia Prevention

Role: collaborator

NCT07630389Recruiting

Remote Assessments and Genetic Determinants of Congenital and Childhood Myotonic Dystrophy

Role: lead

NCT07630402Not ApplicableRecruiting

Optimization of Cardiac Imaging in Women With Early-Stage Breast Cancer

Role: lead

NCT04522791Not ApplicableCompleted

Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)

Role: lead

NCT06941389Recruiting

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

Role: lead

NCT04297605Phase 1Recruiting

Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2

Role: lead

NCT01868451Not ApplicableCompleted

Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma

Role: collaborator

NCT07260968Not ApplicableRecruiting

Facilitating Lactation Through Optimized Workflows - Evaluating the Efficiency of Pumping Protocols and Cellular Mechanisms of Milk Production

Role: lead

NCT05423340Not ApplicableCompleted

Effect of E-Liquid Flavor on Respiratory Symptoms in People Using Electronic Nicotine Delivery Systems

Role: collaborator

NCT03781323Phase 2Active Not Recruiting

Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer

Role: lead

NCT06554353Recruiting

Cardiopulmonary Exercise Testing and Oscillometry for the Evaluation of Dyspnea

Role: lead

NCT05029960Early Phase 1Terminated

Tolerability and Activity of Brivaracetam (BRV) in Patients With Diffuse Gliomas

Role: lead

NCT04550052Terminated

A-SPIRE Heart Failure: Utilizing Health Tags to Identify Patients at Risk for Hospital Readmissions

Role: lead

NCT06977217Active Not Recruiting

Factors Associated With Response to Cardiac Resynchronization Therapy in Heart Failure Patients With Non-LBBB ECG Pattern

Role: lead

NCT03681015Completed

Wearable Assessments in the Clinic and Home in PD

Role: lead